Dr. Broverman leads a spirited discussion in a resource scarce setting (i.e. low amount of vaccine) who should get this life saving treatment? What criteria could be used? What should one use? Who should make these decisions?
Scaling up worldwide disease surveillance and vaccine production is an expensive endeavor. Who is responsible for funding these efforts, and how are these costs distributed among all of those likely to benefit?
- Should the expected financial contribution be based upon ability to pay, likelihood of benefit, or by some other measure?
- Are developed nations morally obligated to providing assistance to developing countries lacking the financial, structural, or intellectual capacity to stage a meaningful response?
Dr. So going through how we currently detect potential pandemics
During the morning session Dr. So brought up how media (news articles) can be used to help detect increasing incidental cases of a potential pandemic (i.e. web news crawler).
What detection techniques do you think are the most cost effective and not prone to false-positives?
Do you have any other ideas or techniques that could be used to improve the accuracy and timing of detection?
A great end of session question to Dr. Schuchat was in regards to the role of media to educating the public to medical issues (i.e. pandemic flu).
What medium do you think is the best to disseminate information to the population in the US (e.g. television, radio, internet, printed materials, …)?
Do you think the media might exaggerate the risk or danger related to H1N1 or other medical issues? How would you propose to address over or under coverage of these items? Is there a “gold standard” news source that you go to for medical related information?
Recent Comments